Healthcare Environments Division, University of North Carolina at Chapel Hill School of Nursing, Chapel Hill, NC 27599-7460, USA.
Nurs Res. 2010 Nov-Dec;59(6):380-8. doi: 10.1097/NNR.0b013e3181f84ee9.
The Beck Depression Inventory, Second Edition (BDI-II), and the Patient Health Questionnaire-9 (PHQ-9) are considered reliable and valid for measuring depressive symptom severity and screening for a depressive disorder. Few studies have examined the convergent or divergent validity of these two measures, and none has been conducted among low-income women-although rates of depression in this group are extremely high. Moreover, variation in within-subject scores suggests that these measures may be less comparable in select subgroups.
We sought to compare these two measures in terms of construct validity and to examine whether within-subject differences in depressive symptom severity scores could be accounted for by select characteristics in low-income women.
In a sample of 308 low-income women, construct validity was assessed using a multitrait-monomethod matrix approach, between-instrument differences in continuous symptom severity scores were regressed on select characteristics using backward stepwise selection, and differences in depressive symptom classification were assessed using the Mantel-Haenszel test.
Convergent validity was high (rs = .80, p < .001). Among predictors that included age, race, education, number of chronic health conditions, history of depression, perceived stress, anxiety, and/or the number of generalized symptoms, none explained within-subject differences in depressive symptom scores between the BDI-II and the PHQ-9 (p > .05, R2 < .04). Similarly, there was consistency in depressive symptom classification (χ2 = 172 and 172.6, p < .0001).
These findings demonstrate that the BDI-II and the PHQ-9 perform similarly among low-income women in terms of depressive symptom severity measurement and classifying levels of depressive symptoms, and do not vary across subgroups on the basis of select demographics.
贝克抑郁量表第二版(BDI-II)和患者健康问卷-9(PHQ-9)被认为是可靠和有效的,可用于衡量抑郁症状严重程度和筛查抑郁障碍。很少有研究检验这两种测量方法的聚合或发散效度,也没有在低收入妇女中进行研究——尽管该人群中的抑郁率极高。此外,个体内评分的差异表明,在某些特定亚组中,这些测量方法可能不太可比。
我们旨在比较这两种测量方法的结构效度,并检验在低收入妇女中,抑郁症状严重程度评分的个体内差异是否可以用某些特征来解释。
在 308 名低收入妇女的样本中,采用多特质-单方法矩阵方法评估结构效度,使用向后逐步选择将两种工具的连续症状严重程度评分的差异回归到某些特征上,并使用 Mantel-Haenszel 检验评估抑郁症状分类的差异。
聚合效度较高(rs =.80,p <.001)。在包括年龄、种族、教育程度、慢性健康状况数量、抑郁史、感知压力、焦虑和/或全身性症状数量在内的预测因子中,没有一个可以解释 BDI-II 和 PHQ-9 之间个体内抑郁症状评分的差异(p >.05,R2 <.04)。同样,抑郁症状分类也具有一致性(χ2 = 172 和 172.6,p <.0001)。
这些发现表明,BDI-II 和 PHQ-9 在评估低收入妇女的抑郁症状严重程度和分类抑郁症状的严重程度方面表现相似,并且在基于某些人口统计学特征的亚组中,评分不会发生变化。